RHON-KLINIKUM AG Reports Stable H1 2026 Results, Expands Regional Health Networks Amid Reform Pressures
Found this article helpful?
Share it with your network and spread the knowledge!
RHON-KLINIKUM AG, one of Germany's largest healthcare providers, has reported a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, slightly above the previous year's EUR 833.5 million. EBITDA rose to EUR 57.0 million from EUR 46.7 million, and consolidated profit increased to EUR 22.5 million from EUR 14.7 million in the prior year period. The company treated 513,700 patients on an outpatient and inpatient basis, a 9% increase compared to 471,295 in the first half of 2025.
These results come as RHON-KLINIKUM continues its targeted investments in expanding regional health networks, a strategy that the company believes is essential for the future of healthcare. Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional collaboration: “Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs.”
The company is actively forging partnerships to enhance care. In Hesse, Universitatsklinikum Marburg and Lungenfachklinik Immenhausen have pooled their expertise to improve lung patient care. In Brandenburg, a new child protection emergency service at the RHON-KLINIKUM Frankfurt (Oder) site has been established, with cooperation agreements among the hospital, the City of Frankfurt (Oder), and the District of Oder-Spree ensuring coordinated help for children and adolescents.
However, the company also faces significant challenges from recent legislative reforms. Dr. Stefan Stranz, another Board member, criticized the Statutory Health Insurance Contribution Rate Stabilization Act, stating, “Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks.”
Looking ahead to the full year 2026, RHON-KLINIKUM expects revenues of EUR 1.7 billion within a range of plus or minus 5%, and EBITDA between EUR 110 million and EUR 125 million. The company also anticipates a moderate improvement in non-financial indicators, such as number of cases and cost weights. However, the forecast is subject to considerable uncertainty due to ongoing regulatory changes, including the Hospital Reform Adjustment Act (KHAG) and the SHI Contribution Rate Stabilisation Act, which are expected to increase financial pressure on hospitals in the short term.
The company notes that global crises and negative economic impacts, including higher prices and supply bottlenecks, add further volatility. Despite these challenges, RHON-KLINIKUM remains committed to its mission of providing high-quality care, with over 19,100 employees treating nearly one million patients annually across its five major facilities. The full interim report is available on the company's website at www.rhoen-klinikum-ag.com.